IBDEI09C ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4302,1,3,0)
 ;;=3^357.2
 ;;^UTILITY(U,$J,358.3,4302,1,4,0)
 ;;=4^POLYNEUROPATHY IN DM
 ;;^UTILITY(U,$J,358.3,4302,2)
 ;;=^96321
 ;;^UTILITY(U,$J,358.3,4303,0)
 ;;=581.81^^37^421^14
 ;;^UTILITY(U,$J,358.3,4303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4303,1,3,0)
 ;;=3^581.81
 ;;^UTILITY(U,$J,358.3,4303,1,4,0)
 ;;=4^NEPHROTIC SYN IN OTH DIS
 ;;^UTILITY(U,$J,358.3,4303,2)
 ;;=^270346
 ;;^UTILITY(U,$J,358.3,4304,0)
 ;;=276.2^^37^422^1
 ;;^UTILITY(U,$J,358.3,4304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4304,1,3,0)
 ;;=3^276.2
 ;;^UTILITY(U,$J,358.3,4304,1,4,0)
 ;;=4^ACIDOSIS
 ;;^UTILITY(U,$J,358.3,4304,2)
 ;;=^2070
 ;;^UTILITY(U,$J,358.3,4305,0)
 ;;=276.3^^37^422^2
 ;;^UTILITY(U,$J,358.3,4305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4305,1,3,0)
 ;;=3^276.3
 ;;^UTILITY(U,$J,358.3,4305,1,4,0)
 ;;=4^ALKALOSIS
 ;;^UTILITY(U,$J,358.3,4305,2)
 ;;=^4889
 ;;^UTILITY(U,$J,358.3,4306,0)
 ;;=276.51^^37^422^3
 ;;^UTILITY(U,$J,358.3,4306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4306,1,3,0)
 ;;=3^276.51
 ;;^UTILITY(U,$J,358.3,4306,1,4,0)
 ;;=4^DEHYDRATION
 ;;^UTILITY(U,$J,358.3,4306,2)
 ;;=^332743
 ;;^UTILITY(U,$J,358.3,4307,0)
 ;;=253.5^^37^422^4
 ;;^UTILITY(U,$J,358.3,4307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4307,1,3,0)
 ;;=3^253.5
 ;;^UTILITY(U,$J,358.3,4307,1,4,0)
 ;;=4^DIABETES INSIPIDUS
 ;;^UTILITY(U,$J,358.3,4307,2)
 ;;=^33572
 ;;^UTILITY(U,$J,358.3,4308,0)
 ;;=276.9^^37^422^5
 ;;^UTILITY(U,$J,358.3,4308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4308,1,3,0)
 ;;=3^276.9
 ;;^UTILITY(U,$J,358.3,4308,1,4,0)
 ;;=4^ELECTROLYTE DISORDER NOS
 ;;^UTILITY(U,$J,358.3,4308,2)
 ;;=^267949
 ;;^UTILITY(U,$J,358.3,4309,0)
 ;;=276.69^^37^422^6
 ;;^UTILITY(U,$J,358.3,4309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4309,1,3,0)
 ;;=3^276.69
 ;;^UTILITY(U,$J,358.3,4309,1,4,0)
 ;;=4^FLUID OVERLOAD NEC
 ;;^UTILITY(U,$J,358.3,4309,2)
 ;;=^339607
 ;;^UTILITY(U,$J,358.3,4310,0)
 ;;=275.42^^37^422^8
 ;;^UTILITY(U,$J,358.3,4310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4310,1,3,0)
 ;;=3^275.42
 ;;^UTILITY(U,$J,358.3,4310,1,4,0)
 ;;=4^HYPERCALCEMIA
 ;;^UTILITY(U,$J,358.3,4310,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,4311,0)
 ;;=276.0^^37^422^9
 ;;^UTILITY(U,$J,358.3,4311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4311,1,3,0)
 ;;=3^276.0
 ;;^UTILITY(U,$J,358.3,4311,1,4,0)
 ;;=4^HYPERNATREMIA
 ;;^UTILITY(U,$J,358.3,4311,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,4312,0)
 ;;=276.7^^37^422^10
 ;;^UTILITY(U,$J,358.3,4312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4312,1,3,0)
 ;;=3^276.7
 ;;^UTILITY(U,$J,358.3,4312,1,4,0)
 ;;=4^HYPERPOTASSEMIA/HYPERKALEMIA
 ;;^UTILITY(U,$J,358.3,4312,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,4313,0)
 ;;=275.41^^37^422^11
 ;;^UTILITY(U,$J,358.3,4313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4313,1,3,0)
 ;;=3^275.41
 ;;^UTILITY(U,$J,358.3,4313,1,4,0)
 ;;=4^HYPOCALCEMIA
 ;;^UTILITY(U,$J,358.3,4313,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,4314,0)
 ;;=588.89^^37^422^12
 ;;^UTILITY(U,$J,358.3,4314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4314,1,3,0)
 ;;=3^588.89
 ;;^UTILITY(U,$J,358.3,4314,1,4,0)
 ;;=4^HYPOKALEMIC NEPHROPATHY
 ;;^UTILITY(U,$J,358.3,4314,2)
 ;;=^88036
 ;;^UTILITY(U,$J,358.3,4315,0)
 ;;=276.1^^37^422^13
 ;;^UTILITY(U,$J,358.3,4315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4315,1,3,0)
 ;;=3^276.1
 ;;^UTILITY(U,$J,358.3,4315,1,4,0)
 ;;=4^HYPONATREMIA
 ;;^UTILITY(U,$J,358.3,4315,2)
 ;;=^60722
 ;;^UTILITY(U,$J,358.3,4316,0)
 ;;=275.3^^37^422^14
 ;;^UTILITY(U,$J,358.3,4316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4316,1,3,0)
 ;;=3^275.3
